CORDIS Project
Funding breakdown and partner intelligence are Premium
Sign in and upgrade to Premium for EU contribution totals, consortium analytics, OpenAlex research context, and AI summaries. · 0 consortium intelligence fields visible of 1
Start free • Cancel anytime • 14-day refund guarantee
This project focuses on developing a personalized cancer therapy by utilizing disease-specific RNA molecules to trigger the synthesis of drug-like compounds. These compounds aim to target cancer cells directly, minimizing side effects on healthy cells by ensuring that the drugs are only activated in the presence of spe…
How could a molecular cancer therapy look like in 2040?
In cancer, gene expression is deregulated due to amplification, mutation and translocation of genes.
Next generation RNA sequencing provides us with the opportunity to identify the number and identity of the gene products aberrantly expressed in a patient.
But do we have methods that take advantage of the personalized sequence data?
In this research project we propose the idea to use the RNA molecules expressed upon disease-type gene expres…
HUMBOLDT-UNIVERSITAET ZU BERLIN
Partner organizations (coordinator is shown above), with normalized type and CORDIS activity type. Guests see up to 4 partners.
Similar projects, consortium collaboration history, frequent partners, and OpenAlex research context.
Guests see up to 5 EuroSciVoc fields.
Guests see up to 5 topics.
